Asia Pacific Pharmaceutical Cro Market Size & Outlook

The pharmaceutical cro market in Asia Pacific is expected to reach a projected revenue of US$ 35,229.5 million by 2033. A compound annual growth rate of 8.6% is expected of Asia Pacific pharmaceutical cro market from 2026 to 2033.
Revenue, 2025 (US$M)
$18,335.3
Forecast, 2033 (US$M)
$35,229.5
CAGR, 2026 - 2033
8.6%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific pharmaceutical cro market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific pharmaceutical cro market highlights

  • The Asia Pacific pharmaceutical cro market generated a revenue of USD 18,335.3 million in 2025.
  • The market is expected to grow at a CAGR of 8.6% from 2026 to 2033.
  • In terms of segment, clinical was the largest revenue generating type in 2025.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2026 to 2033.


Asia Pacific data book summary

Market revenue in 2025USD 18,335.3 million
Market revenue in 2033USD 35,229.5 million
Growth rate8.6% (CAGR from 2026 to 2033)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical
Key market players worldwidePAREXEL, Icon PLC, Thermo Fisher Scientific Inc, Medpace Holdings Inc, IQVIA Holdings Inc, CTI Clinical Trial and Consulting Services, Wuxi AppTec Co Ltd


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 40.5% of the global pharmaceutical cro market in 2025.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 35,229.5 million by 2033.

Clinical was the largest segment with a revenue share of 80.91% in 2025. Horizon Databook has segmented the Asia Pacific pharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.


Asia Pacific held the largest market share of 46.40% in 2024, attributed to various factors, such as the stringent standards for patient safety in conducting clinical trials, cheap labor, and access to a large patient pool, which are propelling market growth.

In addition, the rising adoption of global R&D standards to meet international requirements and low operating costs are key factors responsible for the growing demand for outsourcing services across the Asia Pacific region. Likewise, the development of outsourcing hubs, the expansion of market players, and the availability of skilled practitioners further contribute to the market's growth.

For instance, in March 2024, TFS Health Science announced the expansion in the Asia Pacific region, establishing an operational base in Australia. The expansion will allow the company to provide comprehensive clinical research services & support partners with a broader reach to patients, fostering innovative solutions & global collaboration.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical CRO Market Companies

Name Profile # Employees HQ Website
CTI Clinical Trial and Consulting Services View profile 501-1000 Covington, Kentucky, United States, North America http://ctifacts.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Asia Pacific pharmaceutical cro market size, by country, 2021-2033 (US$M)

Asia Pacific Pharmaceutical CRO Market Outlook Share, 2025 & 2033 (US$M)

Asia Pacific pharmaceutical cro market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online